Orrick Herrington & Sutcliffe advised Ipsen on the deal. Global biopharmaceutical company Ipsen (Euronext: IPN; ADR: IPSEY) announced its definitive agreement to acquire Epizyme (Nasdaq: EPZM), a...
Ipsen’s Acquisition of Epizyme
Bain Capital Tech Opportunities’ $200 Million Investment in When I Work
Kirkland & Ellis advised Bain Capital Tech Opportunities, while Orrick, Herrington & Sutcliffe advised When I Work in the transaction. When I Work, a leading SaaS...
Unity’s $1.6 Billion Assets Acquisition of Weta Digital
Morrison & Foerster advised Unity on the deal while Orrick represented Weta Digital. Unity (NYSE: U), a leading platform for creating and operating real-time 3D content,...
Local Bounti’s $1.1 Billion SPAC Merger with Leo Holdings
Orrick Herrington & Sutcliffe LLP advised Local Bounti on the deal., while Kirkland & Ellis LLP served as legal advisor to Leo. Debevoise & Plimpton LLP...
Green Dot’s $165 Million Acquisition of Tax Refund Unit from Republic Bank
Orrick Herrington & Sutcliffe LLP advised Green Dot, while Wachtell, Lipton, Rosen & Katz advised Republic Bank on the deal. Green Dot Corporation (NYSE: GDOT) (“Green...
SOC Telemed’s $194 Million Acquisition of Access Physicians
Orrick Herrington & Sutcliffe LLP advised SOC Telemed, Inc. on the deal. SOC Telemed, Inc. (Nasdaq: TLMD), the leading national provider of acute telemedicine technology and...